Form 4: Akero Therapeutics Executive Lamy Patrick Executes Stock Option and Sells Shares
SEC Form 4 Filing
Senior VP of Commercial Strategy at Akero Therapeutics, Patrick Lamy, exercised stock options and sold shares on March 3, 2025, according to a recent SEC filing.
Summary
- On March 3, 2025, Patrick Lamy, Senior VP of Commercial Strategy at Akero Therapeutics, exercised a stock option to acquire 1,000 shares of common stock at a price of $19.87 per share.
- Simultaneously, Lamy sold 1,000 shares of Akero Therapeutics common stock at a price of $48.09 per share.
- Following these transactions, Lamy directly owns 33,492 shares of Akero Therapeutics common stock.
- Lamy also holds options to purchase 78,182 shares of common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
There is no future outlook provided in this document.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| December 8, 2023 | Commencement date for the monthly vesting of the stock option. |
| March 28, 2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| March 3, 2025 | Date of the stock option exercise and share sale. |
| March 5, 2025 | Date of the signature on the SEC filing. |
| December 7, 2033 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.